1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-12318G IBMX (GMP)

3-异丁基-1-甲基黄嘌呤

Phosphodiesterase (PDE)

Inflammation/Immunology

2022-12 IBMX (GMP)
HY-P99315 Ruplizumab

卢利珠单抗

TNF Receptor

Inflammation/Immunology

2022-12 Ruplizumab
HY-P99280 Bimekizumab

Interleukin Related

Inflammation/Immunology

2022-12 Bimekizumab
HY-148417 ZZL-7

Serotonin Transporter

Neurological Disease

2022-12 ZZL-7
HY-P99410 Ordesekimab

奥司奇单抗

Interleukin Related

Inflammation/Immunology

2022-12 Ordesekimab
HY-B0166G L-Ascorbic acid (GMP)

L-抗坏血酸; 维生素C

Calcium Channel

Cancer;

Metabolic Disease;

Neurological Disease

2022-12 L-Ascorbic acid (GMP)
HY-P99326 Tositumomab

CD20

Cancer

2022-12 Tositumomab
HY-P99319 Talizumab

Others

Inflammation/Immunology

2022-12 Talizumab
HY-P99320 Tarextumab

他瑞妥单抗

Notch

Cancer

2022-12 Tarextumab
HY-151881 SOS1-IN-15

Ras

Cancer

2022-12 SOS1-IN-15
HY-P99321 Teneliximab

TNF Receptor

Cancer;

Inflammation/Immunology

2022-12 Teneliximab
HY-P99322 Tesidolumab

Complement System

Inflammation/Immunology

2022-12 Tesidolumab
HY-P99318 Sonepcizumab

LPL Receptor

Cancer

2022-12 Sonepcizumab
HY-P99317 Solanezumab

索拉珠单抗

Amyloid-β

Neurological Disease

2022-12 Solanezumab
HY-P99316 Sirukumab

西鲁库单抗

Interleukin Related

Inflammation/Immunology

2022-12 Sirukumab
HY-P99323 Timolumab

AP-1

Inflammation/Immunology

2022-12 Timolumab
HY-151905 D6808

c-Met/HGFR

Cancer

2022-12 D6808
HY-148407 lucPpy-IN-1

Others

Others

2022-12 lucPpy-IN-1
HY-151900 SARS-CoV-2 Mpro-IN-4

SARS-CoV; Virus Protease

Infection

2022-12 SARS-CoV-2 Mpro-IN-4
HY-151882 EGFR-IN-73

EGFR

Cancer

2022-12 EGFR-IN-73